Can INSTI-associated Weight Gain be Halted or Reversed With a Switch to Doravirine/Lamivudine/Tenofovir DF?
Clinical trial NCT04665375 · TERMINATED
Trial details
- NCT number
- NCT04665375
- Sponsor
- University Health Network, Toronto
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-26
- Primary completion
- 2024-03-31
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.